FDA approves device to treat obesity

On January 14, the U.S. Food and Drug Administration (FDA) approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here